Every listed Indian specialty chemicals company covered here — Navin Fluorine, Aarti, Acutaas, Aether, Gujarat Fluorochemicals, PI Industries, SRF — against Deepak Nitrite, on the same numbers from the same filings. Click a column to rank by it. Tick up to three and press Compare for the full side-by-side.
| Company | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | ₹75.2k Cr | 41.0× | 7.4% | 21.6% | 14.1% | 1.6× | 0.4× | -12.9% | |
| 2 | ₹49.3k Cr | 87.8× | 5.5% | 25.8% | 9.7% | 1.4× | 0.3× | 15.4% | |
| 3 | ₹43.3k Cr | 65.2× | 41.1% | 32.6% | 21.2% | 1.8× | 0.3× | 79.0% | |
| 4 | ₹36.6k Cr | 27.7× | -15.8% | 25.8% | 15.9% | 0.8× | 0.0× | -34.3% | |
| 5 | ₹26.3k Cr | 73.9× | 33.0% | 35.9% | 32.3% | 1.0× | 0.0× | 120.1% | |
| vs | 6Deepak Nitrite | ₹22.0k Cr | 40.0× | -4.8% | 12.5% | 11.4% | 1.0× | 0.3× | -10.9% |
| 7 | ₹21.8k Cr | 99.4× | 38.3% | 31.3% | 11.6% | 0.5× | 0.2× | 118.7% | |
| 8 | ₹18.0k Cr | 42.9× | 14.0% | 14.1% | 6.9% | 2.8× | 0.8× | 27.3% |
Market cap, P/E and the 12-month return move with the market and are dated to the last close. Every other column is the last full financial year. n/m — loss-making, so the multiple means nothing. A dash means not recorded, which is not the same as nil.
| Metric | DEEPAKNTR | NAVINFLUOR |
|---|---|---|
| What you pay22 Sept 2026 | ||
| Share price | ₹1,613.20 | ₹8,438.00 |
| Market cap | ₹22,004 Cr | ₹43,287 Cr |
| P/E | 39.97× | 65.24× |
| P/B | 3.77× | 10.89× |
| P/S | 2.79× | 13.06× |
| 12-month return | -10.9% | 79.0% |
| SizeFY26 | ||
| Revenue | ₹7,887 Cr | ₹3,314 Cr |
| PAT | ₹551 Cr | ₹664 Cr |
| Net worth | ₹5,837 Cr | ₹3,975 Cr |
| Gross block | ₹3,270 Cr | ₹3,324 Cr |
| GrowthFY26 | ||
| Revenue growth | -4.8% | 41.1% |
| Revenue CAGR (3y) | -0.4% | 16.8% |
| PAT CAGR (3y) | -13.5% | 20.9% |
| What it keepsFY26 | ||
| EBITDA margin | 12.5% | 32.6% |
| PAT margin | 7.0% | 20.0% |
| ROCE | 11.4% | 21.2% |
| ROE | 9.4% | 16.7% |
| CFO / PAT (3y) | 0.99× | 1.81× |
| What it owesFY26 | ||
| Net debt | ₹1,369 Cr | ₹1,175 Cr |
| Debt / equity | 0.28× | 0.32× |
| CWIP | ₹1,828 Cr | ₹143 Cr |
| Debtor days | 70 days | 83 days |
| Who owns itFY26 | ||
| Promoter holding | 49.3% | 27.1% |
| Institutional holding | 30.0% | 52.2% |
Every figure comes from the same filings the company pages are built from. A dash means the figure is not recorded, which is not the same as nil.
Deepak Nitrite runs two businesses: phenolics, where it is India's largest producer of phenol, acetone and isopropyl alcohol, at ₹1,775 crore of June-quarter revenue, and advanced intermediates for agrochemicals, pharmaceuticals, paper and personal care at ₹804 crore. Seven plants across five locations, exports to more than 50 countries, 85% of sales domestic. The year to March 2026 was poor — revenue down 4.8% and profit down 21% — and then the June quarter delivered a 21% EBITDA margin against 11% and profit up 207%.
Navin turns hydrofluoric acid into three different kinds of product, and the split matters more than the total: high-performance products, mainly the refrigerant R32, at ₹540 crore in the June quarter; specialty chemicals, largely intermediates for agrochemical and pharmaceutical innovators, at ₹325 crore; and contract manufacturing for pharma at ₹180 crore. Together ₹1,045 crore, up 44%. Operating margin was 34.2% in the quarter and return on capital nearly doubled to 21.2%. It has been handling fluorine since 1967.
By building, and on a scale that dwarfs the company. No acquisitions; gross block rose 33% to ₹3,270 crore with a further ₹1,828 crore in construction — more than half the completed base again, waiting to be switched on. MIBK, MIBC and acetophenone commission in August 2026, with an agrochemical intermediates plant and an alkylation plant behind them. Then the ₹11,500 crore propylene-to-polycarbonate project for 2028, which includes a plant being physically dismantled at Stade in Germany and shipped to Dahej.
Built, not bought, and expensively. No acquisitions; gross block rose 21% to ₹3,324 crore with ₹1,235 crore of cash going out through investing. The projects are named and dated: a ₹288 crore cGMP4 block for contract manufacturing with phase two initiated in August 2026 for completion by March 2027, HFC capacity equal to 15,000 tonnes of R32 due in the December quarter, Dahej debottlenecking on the same timetable, and a ₹90 crore advanced materials plant.
A founder still in the chair at the top, and both his sons made deputy managing directors on the same day. Dr Deepak C. Mehta is chairman and managing director — both roles, one person — and on 9 May 2026 Maulik and Meghav Mehta were each appointed deputy managing director. The independent bench is substantial and Dileep Choksi chairs the audit committee with no family member on it, which is the arrangement that matters most. Deloitte signed FY26 without qualification.
A fourth-generation industrial family holding about a quarter of the company and running it with hired professionals. Vishad Mafatlal is executive chairman, but Nitin Kulkarni as managing director and Anish Ganatra as chief financial officer were both recruited rather than born into it. The board runs to eleven with six independents, and Price Waterhouse signed FY26 without qualification. Where the trust question bites is small and worth naming: a relative of the chairman joined the payroll in August 2025.
On what changed underneath the margin: “we're no longer a nitration company that buys nitric acid, we're now a nitrogen company that nitrates.”
Deepak Nitrite management · Q1 FY27
Two plants slipped a couple of months on contract labour shortages and a national gas shortage.
Deepak Nitrite management · Q1 FY27
Phase two of the cGMP4 block, ₹125 crore, was initiated in August 2026 for completion by March 2027.
Navin Fluorine management · Q1 FY27
Additional HFC capacity equivalent to 15,000 tonnes of R32 is due in the December 2026 quarter.
Navin Fluorine management · Q1 FY27
Closing prices to 22 Sept 2026, adjusted for bonuses and splits. Dividends are not counted. This is what happened, not what will.
A sector, read end to end, and the companies as they are published. Roughly monthly. Nothing else, and one click to stop.